A detailed history of Ing Groep Nv transactions in Biogen Inc. stock. As of the latest transaction made, Ing Groep Nv holds 19,650 shares of BIIB stock, worth $3.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,650
Previous 24,595 20.11%
Holding current value
$3.1 Million
Previous $5.7 Million 33.2%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$189.07 - $236.8 $934,951 - $1.17 Million
-4,945 Reduced 20.11%
19,650 $3.81 Million
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $5.77 Million - $7.17 Million
-30,303 Reduced 55.2%
24,595 $5.7 Million
Q1 2024

May 10, 2024

BUY
$212.02 - $267.71 $1.15 Million - $1.45 Million
5,406 Added 10.92%
54,898 $11.8 Million
Q4 2023

Feb 08, 2024

BUY
$222.59 - $267.94 $114,856 - $138,257
516 Added 1.05%
49,492 $12.8 Million
Q3 2023

Oct 27, 2023

BUY
$253.3 - $285.89 $1.3 Million - $1.47 Million
5,128 Added 11.69%
48,976 $12.6 Million
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $20.3 Million - $23.4 Million
-73,710 Reduced 62.7%
43,848 $12.5 Million
Q1 2023

May 09, 2023

BUY
$256.56 - $292.34 $13.3 Million - $15.1 Million
51,662 Added 78.4%
117,558 $32.7 Million
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $8.06 Million - $9.79 Million
31,932 Added 94.02%
65,896 $18.2 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $416,247 - $573,967
-2,138 Reduced 5.92%
33,964 $9.07 Million
Q2 2022

Aug 08, 2022

BUY
$187.54 - $223.02 $798,732 - $949,842
4,259 Added 13.37%
36,102 $7.36 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $691,758 - $871,579
-3,570 Reduced 10.08%
31,843 $6.71 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $2.3 Million - $2.96 Million
10,278 Added 40.89%
35,413 $8.5 Million
Q3 2021

Nov 02, 2021

BUY
$282.99 - $369.05 $32,543 - $42,440
115 Added 0.46%
25,135 $7.11 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $1.28 Million - $2.05 Million
4,934 Added 24.56%
25,020 $8.66 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $29,396 - $34,440
-121 Reduced 0.6%
20,086 $5.62 Million
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $1.58 Million - $2.38 Million
6,703 Added 49.64%
20,207 $4.95 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $562,371 - $649,328
2,124 Added 18.66%
13,504 $3.83 Million
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $1.79 Million - $2.37 Million
-6,927 Reduced 37.84%
11,380 $3.05 Million
Q1 2020

May 06, 2020

SELL
$268.85 - $341.04 $1.09 Million - $1.39 Million
-4,070 Reduced 18.19%
18,307 $5.79 Million
Q4 2019

Feb 10, 2020

BUY
$220.06 - $304.07 $190,792 - $263,628
867 Added 4.03%
22,377 $6.64 Million
Q3 2019

Nov 08, 2019

BUY
$217.44 - $243.88 $2.62 Million - $2.94 Million
12,049 Added 127.35%
21,510 $5.01 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $12.9 Million - $14.2 Million
-58,911 Reduced 86.16%
9,461 $2.21 Million
Q1 2019

May 13, 2019

BUY
$216.71 - $338.96 $1.21 Million - $1.89 Million
5,590 Added 8.9%
68,372 $16.2 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $4.41 Million - $5.59 Million
15,850 Added 33.77%
62,782 $18.9 Million
Q3 2018

Nov 06, 2018

BUY
$293.51 - $383.83 $5.76 Million - $7.53 Million
19,621 Added 71.84%
46,932 $16.6 Million
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $7.14 Million - $8.51 Million
-27,725 Reduced 50.38%
27,311 $7.93 Million
Q1 2018

May 07, 2018

BUY
$260.13 - $367.91 $36,938 - $52,243
142 Added 0.26%
55,036 $15.1 Million
Q4 2017

Feb 06, 2018

SELL
$307.64 - $344.58 $917,690 - $1.03 Million
-2,983 Reduced 5.15%
54,894 $17.5 Million
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $16.3 Million - $19.1 Million
57,877
57,877 $18.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.